BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16206083)

  • 1. Treatment of African trypanosomiasis with cordycepin and adenosine deaminase inhibitors in a mouse model.
    Rottenberg ME; Masocha W; Ferella M; Petitto-Assis F; Goto H; Kristensson K; McCaffrey R; Wigzell H
    J Infect Dis; 2005 Nov; 192(9):1658-65. PubMed ID: 16206083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of treatment with 3'-deoxyadenosine associated deoxycoformycin on hematological parameters and activity of adenosine deaminase in infected mice with Trypanosoma evansi.
    Dalla Rosa L; Da Silva AS; Ruchel JB; Gressler LT; Oliveira CB; França RT; Lopes ST; Leal DB; Monteiro SG
    Exp Parasitol; 2013 Oct; 135(2):357-62. PubMed ID: 23933282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Trypanosoma evansi to cordycepin.
    Da Silva AS; Wolkmer P; Nunes JT; Duck MR; Oliveira CB; Gressler LT; Costa MM; Zanette RA; Mazzanti CM; Lopes ST; Monteiro SG
    Biomed Pharmacother; 2011 Jun; 65(3):220-3. PubMed ID: 21620640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with 3'-deoxyadenosine and deoxycoformycin in mice infected by Trypanosoma cruzi and its side effect on purinergic enzymes.
    do Carmo GM; Doleski PH; de Sá MF; Grando TH; Azevedo MI; Manzoni AG; Leal DBR; Gressler LT; Henker LC; Mendes RE; Baldissera MD; Monteiro SG; Stefani LM; Da Silva AS
    Microb Pathog; 2017 Dec; 113():51-56. PubMed ID: 29051060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis.
    Vodnala SK; Lundbäck T; Yeheskieli E; Sjöberg B; Gustavsson AL; Svensson R; Olivera GC; Eze AA; de Koning HP; Hammarström LG; Rottenberg ME
    J Med Chem; 2013 Dec; 56(24):9861-73. PubMed ID: 24283924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cordycepin (3'-deoxyadenosine) and pentostatin (deoxycoformycin) against Trypanosoma cruzi.
    do Carmo GM; de Sá MF; Grando TH; Gressler LT; Baldissera MD; Monteiro SG; Henker LC; Mendes RE; Stefani LM; Da Silva AS
    Exp Parasitol; 2019 Apr; 199():47-51. PubMed ID: 30825499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical assessment of the treatment of second-stage African trypanosomiasis with cordycepin and deoxycoformycin.
    Vodnala SK; Ferella M; Lundén-Miguel H; Betha E; van Reet N; Amin DN; Oberg B; Andersson B; Kristensson K; Wigzell H; Rottenberg ME
    PLoS Negl Trop Dis; 2009 Aug; 3(8):e495. PubMed ID: 19652702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the HSP60/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness.
    Abdeen S; Salim N; Mammadova N; Summers CM; Goldsmith-Pestana K; McMahon-Pratt D; Schultz PG; Horwich AL; Chapman E; Johnson SM
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5247-5253. PubMed ID: 27720295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cordycepin (3'-deoxyadenosine) pentostatin (deoxycoformycin) combination treatment of mice experimentally infected with Trypanosoma evansi.
    Dalla Rosa L; da Silva AS; Gressler LT; Oliveira CB; Dambrós MG; Miletti LC; França RT; Lopes ST; Samara YN; da Veiga ML; Monteiro SG
    Parasitology; 2013 Apr; 140(5):663-71. PubMed ID: 23361035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose finding of 3'deoxyadenosine and deoxycoformycin for the treatment of Trypanosoma evansi infection: An effective and nontoxic dose.
    Dalla Rosa L; Da Silva AS; Oliveira CB; Gressler LT; Arnold CB; Baldissera MD; Sagrillo M; Sangoi M; Moresco R; Mendes RE; Weiss PE; Miletti LC; Monteiro SG
    Microb Pathog; 2015 Aug; 85():21-8. PubMed ID: 26025154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suramin and minocycline treatment of experimental African trypanososmiasis at an early stage of parasite brain invasion.
    Amin DN; Masocha W; Ngan'dwe K; Rottenberg M; Kristensson K
    Acta Trop; 2008 Apr; 106(1):72-4. PubMed ID: 18329619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel drugs for human African trypanosomiasis.
    Brun R; Don R; Jacobs RT; Wang MZ; Barrett MP
    Future Microbiol; 2011 Jun; 6(6):677-91. PubMed ID: 21707314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma brucei Methylthioadenosine Phosphorylase Protects the Parasite from the Antitrypanosomal Effect of Deoxyadenosine: IMPLICATIONS FOR THE PHARMACOLOGY OF ADENOSINE ANTIMETABOLITES.
    Vodnala M; Ranjbarian F; Pavlova A; de Koning HP; Hofer A
    J Biol Chem; 2016 May; 291(22):11717-26. PubMed ID: 27036940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of ascofuranone in a consecutive treatment on Trypanosoma brucei brucei in mice.
    Yabu Y; Yoshida A; Suzuki T; Nihei C; Kawai K; Minagawa N; Hosokawa T; Nagai K; Kita K; Ohta N
    Parasitol Int; 2003 Jun; 52(2):155-64. PubMed ID: 12798927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,4-Diaminopyrimidines as potent inhibitors of Trypanosoma brucei and identification of molecular targets by a chemical proteomics approach.
    Mercer L; Bowling T; Perales J; Freeman J; Nguyen T; Bacchi C; Yarlett N; Don R; Jacobs R; Nare B
    PLoS Negl Trop Dis; 2011 Feb; 5(2):e956. PubMed ID: 21347454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anilinoquinoline based inhibitors of trypanosomatid proliferation.
    Ferrins L; Sharma A; Thomas SM; Mehta N; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Gillingwater K; Pollastri MP
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006834. PubMed ID: 30475800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor.
    Bacchi CJ; Nathan HC; Yarlett N; Goldberg B; McCann PP; Bitonti AJ; Sjoerdsma A
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2736-40. PubMed ID: 1482141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining tubercidin and cordycepin scaffolds results in highly active candidates to treat late-stage sleeping sickness.
    Hulpia F; Mabille D; Campagnaro GD; Schumann G; Maes L; Roditi I; Hofer A; de Koning HP; Caljon G; Van Calenbergh S
    Nat Commun; 2019 Dec; 10(1):5564. PubMed ID: 31804484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro and in vivo anti-Trypanosoma brucei activities of phenazinomycin and related compounds.
    Otoguro K; Ishiyama A; Iwatsuki M; Namatame M; Nishihara-Tukashima A; Nakashima T; Shibahara S; Kondo S; Yamada H; Omura S
    J Antibiot (Tokyo); 2010 Sep; 63(9):579-81. PubMed ID: 20588299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.